Indicator | Comparison A comparison between a company and a defined peer group. Learn More ↗ Opens in a New Tab | Rank |
|---|---|---|
Revenue | 3,981,267 € | 9 / 2,133+6.8% |
Net Profit | 3,061,651 € | 2 / 2,142+1.2% |
Assets | 7,033,742 € | 11 / 2,139+71.1% |
Equity | 6,940,292 € | 7 / 2,052+79.1% |
Company Age | 5 years · | 1,399 / 2,201 |
Net profit as a share of revenue.
Equity as a share of total assets.
Indicator | 2025Latest | 2024 | 2023 |
|---|---|---|---|
Revenue | 3,981,267 € +6.8% | 3,727,902 € | 1,077,172 € |
Net Profit | 3,061,651 € +1.2% | 3,025,163 € | 742,956 € |
Assets | 7,033,742 € +71.1% | 4,110,756 € | 963,681 € |
LiabilitiesAmounts a company owes to lenders, suppliers, and other creditors. Learn More ↗ Opens in a New Tab | 93,450 € -60.2% | 234,615 € | 5,036 € |
Equity | 6,940,292 € +79.1% | 3,876,141 € | 958,645 € |
EmployeesThe reported number of employees for the accounting period. Learn More ↗ Opens in a New Tab | 0 | 0 | 0 |
Industry | Code | Share | Revenue |
|---|---|---|---|
All Other Professional, Scientific and Technical Activities N.E.C. | 74.99 | 100.0% | 3,981,267 € |
Name | Born | Roles A registered connection between a person or organisation and a company. Learn More ↗ Opens in a New Tab | |
|---|---|---|---|
- | Contact Person | ||
- | Board Member · Beneficial Owner · Founder | ||
- | Board Member · Beneficial Owner · Founder | ||
- | Shareholder 100.00% |
Name | Born | Nationality | Registered | |
|---|---|---|---|---|
- | - | |||
- | - |
Name | Registered | Until |
|---|---|---|
- | ||
- |
Name | Born | Position | Registered | |
|---|---|---|---|---|
- | ||||
- | ||||
- |
Category | Scope | Number | Status | Expiry |
|---|---|---|---|---|
Medical Devices | · EU medical-device regulated actor | EE-AR-000039266 | Valid | - |
Value | Record | Date |
|---|---|---|
Authorised representative | EUDAMED Actor Registration | - |
In 2025: revenue 4 million €, profit 3.1 million €, no employees. Share capital 10,000 €. Beneficial owners: Nathan Andrew Dundovic, Sophie Marie Dundovic.